After the treatment of 5FU-resistant SNU-C5 (SNU-C5/5FUR) cells with 5FU, the knockdown of PGC-1α increased the sensitivity of these cells to this anti-cancer drug via a reduction in the mitochondrial function and the induction of ER stress and apoptosis. The gene discussed is PPARGC1A; the disease is cancer.